Filing Details

Accession Number:
0001214659-25-009864
Form Type:
13G Filing
Publication Date:
2025-06-30 20:00:00
Filed By:
MYDA Advisors LLC
Company:
Smartkem Inc.
Filing Date:
2025-07-01
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
MYDA Advisors LLC 0 217,127 4.9%
MYDA Capital GP, LLC 0 217,127 4.9%
MYDA Advantage LP 0 217,127 4.9%
Jason Lieber 0 217,127 4.9%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  The shares of the Common Stock reported herein consist of 180,000 shares of Common Stock and warrants to purchase 333,333 shares of Common Stock, subject to a 4.99% beneficial ownership limitation. The percentages reported in this Schedule 13G are based on 4,431,165 shares of Common Stock outstanding as of May 12, 2025, as reported in the Form 10-Q filed by the Issuer on May 13, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  The shares of the Common Stock reported herein consist of 180,000 shares of Common Stock and warrants to purchase 333,333 shares of Common Stock, subject to a 4.99% beneficial ownership limitation. The percentages reported in this Schedule 13G are based on 4,431,165 shares of Common Stock outstanding as of May 12, 2025, as reported in the Form 10-Q filed by the Issuer on May 13, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  The shares of the Common Stock reported herein consist of 180,000 shares of Common Stock and warrants to purchase 333,333 shares of Common Stock, subject to a 4.99% beneficial ownership limitation. The percentages reported in this Schedule 13G are based on 4,431,165 shares of Common Stock outstanding as of May 12, 2025, as reported in the Form 10-Q filed by the Issuer on May 13, 2025.


SCHEDULE 13G



Comment for Type of Reporting Person:  The shares of the Common Stock reported herein consist of 180,000 shares of Common Stock and warrants to purchase 333,333 shares of Common Stock, subject to a 4.99% beneficial ownership limitation. The percentages reported in this Schedule 13G are based on 4,431,165 shares of Common Stock outstanding as of May 12, 2025, as reported in the Form 10-Q filed by the Issuer on May 13, 2025.


SCHEDULE 13G


 
MYDA Advisors LLC
 
Signature:/s/ Jason Lieber
Name/Title:Managing Member
Date:06/30/2025
 
MYDA Capital GP, LLC
 
Signature:/s/ Jason Lieber
Name/Title:Managing Member
Date:06/30/2025
 
MYDA Advantage LP
 
Signature:/s/ Jason Lieber
Name/Title:Managing Member of GP
Date:06/30/2025
 
Jason Lieber
 
Signature:/s/ Jason Lieber
Name/Title:Jason Lieber
Date:06/30/2025